Thus, constitutive expression of IL-2 in NK-92 cells through genetic modification leads to auto-activated and -proliferating cells, which reduces the manufacturing costs as well as potentially increases the in vivo tumor reactivity (87, 88). This evidence concerns the gene IL2 and neoplasm.